This paper is in the following e-collection/theme issue:

Systematic Review Protocols (funded) (26)

Published on in Vol 8, No 1 (2019): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11637, first published .
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review

Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review

Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review

Authors of this article:

Mohammed M Mohiuddin1 Author Orcid Image ;   Glenio Mizubuti1 Author Orcid Image ;   Simon Haroutounian2 Author Orcid Image ;   Shannon Smith3 Author Orcid Image ;   Fiona Campbell4 Author Orcid Image ;   Rex Park1 Author Orcid Image ;   Ian Gilron1, 5, 6 Author Orcid Image
Article Authors Cited by (6) Tweetations (4) Metrics

Journals

  1. Fisher E, Eccleston C, Degenhardt L, Finn D, Finnerup N, Gilron I, Haroutounian S, Krane E, Rice A, Rowbotham M, Wallace M, Moore R. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials. PAIN Reports 2019;4(3):e741 View
  2. Gilron I, Blyth F, Degenhardt L, Di Forti M, Eccleston C, Haroutounian S, Moore A, Rice A, Wallace M. Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment: protocol for an overview of systematic reviews. PAIN Reports 2019;4(3):e742 View
  3. Mohiuddin M, Mizubuti G, Haroutounian S, Smith S, Rice A, Campbell F, Park R, Gilron I. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain. The Clinical Journal of Pain 2020;36(4):302 View
  4. Alkhudhayri S, Sajini R, Alharbi B, Qabbani J, Al‐Hindi Y, Fairaq A, Yousef A. Investigating the beneficial effect of aliskiren in attenuating neuropathic pain in diabetic Sprague‐Dawley rats. Endocrinology, Diabetes & Metabolism 2021;4(2) View
  5. Ávila N, Juste F, Costa J, Andrade C. Ensaio clínico de tratamento – em três modalidades – para crianças com distúrbios da fluência e gagueira. CoDAS 2022;34(2) View
  6. Lalsare S. Cannabinoids: Legal aspects, pharmacology, phytochemistry, probable targets from biological system, and therapeutic potential. Asian Journal of Pharmaceutical Research and Health Care 2022;14(3):127 View